Metabolic alkalosis is the most common acid-base disorder in hospitalized and critically ill patients, characterized by primary elevation of serum bicarbonate (>26 mEq/L) and arterial pH (>7.45), with compensatory hypoventilation raising PaCO2. [1-2] The two most common causes — vomiting and diuretic use — account for the majority of cases. [2] The critical diagnostic branch point is the urine chloride, which distinguishes chloride-responsive from chloride-resistant forms and directly dictates treatment. [2-3]
The following figure from Berend et al. provides a systematic diagnostic algorithm for evaluating alkalemia:
1. History
- Key HPI questions: Duration and frequency of vomiting or NG suction; diuretic use (type, dose, recent changes); antacid or calcium carbonate intake; licorice ingestion; laxative use; alcohol use
- Symptom characterization: Often clinically silent in mild cases. Symptoms when present include weakness, muscle cramps, paresthesias, lightheadedness, confusion [3]
- Timing/triggers: Acute (vomiting, NG drainage, diuretic bolus) vs. chronic (ongoing diuretic therapy, surreptitious vomiting, mineralocorticoid excess)
- Associated symptoms: Polyuria, polydipsia (hypokalemia-related), palpitations, tetany, seizures in severe cases [4]
- Important negatives: Absence of vomiting or diuretic use should prompt evaluation for mineralocorticoid excess or genetic tubulopathies [2][5]
2. Alarm Features
- pH ≥ 7.55 is associated with significantly increased mortality in critically ill patients [1]
- pH > 7.60 (severe alkalemia): Arteriolar vasoconstriction compromising cerebral and myocardial perfusion; seizures, lethargy, delirium, stupor [4]
- Potassium < 2.0 mEq/L: Risk of life-threatening cardiac arrhythmias [4][6]
- Refractory supraventricular or ventricular arrhythmias, especially in patients with underlying heart disease [4]
- Respiratory depression with hypercapnia and hypoxemia — can frustrate ventilator weaning even with mild alkalemia [4]
- Tetany from reduced ionized calcium [4]
3. Medications
Causative medications
- Loop diuretics (furosemide, bumetanide) and thiazide diuretics — most common drug cause [2][4]
- Combination diuretic regimens (e.g., furosemide + metolazone) — high risk for "contraction alkalosis" [4]
- Exogenous alkali: sodium bicarbonate, calcium carbonate, citrate, lactate, acetate (in TPN) [4]
- Fludrocortisone and high-dose glucocorticoids (mineralocorticoid effect) [4]
- Cation-exchange resins co-administered with aluminum hydroxide [4]
Treatments
- Normal saline (0.9% NaCl) + KCl — first-line for chloride-responsive forms [2][7]
- Acetazolamide 250–375 mg once or twice daily — promotes bicarbonaturia (monitor for kaliuresis) [4]
- Potassium-sparing diuretics (spironolactone, amiloride, triamterene) — useful adjuncts, especially in CHF [4][8]
- H2-blockers or PPIs — reduce gastric acid loss if NG drainage must continue [4]
- Hydrochloric acid infusion (0.1–0.2 N HCl via central line) — reserved for life-threatening, refractory cases [4]
Contraindications/cautions
- Avoid further alkali administration (bicarbonate, citrate, acetate-containing fluids) [4]
- KCl must be used cautiously in renal failure (hyperkalemia risk) [4]
4. Diet
- Acute: Oral intake often limited; focus on IV repletion
- Chronic/outpatient: Avoid excessive antacid use (calcium carbonate, milk-alkali syndrome); avoid licorice (glycyrrhizin mimics mineralocorticoid excess) [1][4]
- Hydration: Encourage adequate oral fluid and salt intake once tolerating PO
- Potassium-rich foods (bananas, oranges, potatoes) for chronic mild hypokalemia
5. Review of Systems
- Neuro: Headache, confusion, lethargy, paresthesias, tetany, seizures [4]
- Cardiac: Palpitations, chest pain (reduced anginal threshold), syncope [4]
- GI: Nausea, vomiting, abdominal pain, diarrhea (laxative abuse), constipation
- Musculoskeletal: Weakness, cramps (hypokalemia)
- Respiratory: Dyspnea, shallow breathing (compensatory hypoventilation) [1]
- Renal/GU: Polyuria (hypokalemia-induced nephrogenic DI)
6. Collateral History and Family History
- Collateral: Surreptitious vomiting (eating disorders), laxative abuse, diuretic misuse — often denied by patient [4]
- Family history: Bartter syndrome, Gitelman syndrome (autosomal recessive); Liddle syndrome (autosomal dominant); 11β-hydroxysteroid dehydrogenase deficiency; cystic fibrosis [1][5]
- Social context: Eating disorders (bulimia nervosa), performance-enhancing diuretic use, herbal supplement use (licorice root)
7. Risk Factors
- Vomiting/NG suction — most common GI cause [2][4]
- Diuretic therapy — most common renal cause, especially in CHF [4][8]
- Hospitalization/ICU stay — metabolic alkalosis is the most common acid-base disorder in critically ill patients [9]
- CHF — neurohormonal activation amplifies tendency toward alkalosis [8]
- Chronic kidney disease — impaired bicarbonate excretion [1]
- Hypokalemia and hypomagnesemia — both generate and maintain alkalosis [1-2]
- Massive edema states treated with aggressive diuresis [4]
- Post-hypercapnic state — rapid correction of chronic respiratory acidosis
8. Differential Diagnosis
The key diagnostic framework divides metabolic alkalosis by urine chloride: [2]
Chloride-responsive (UCl < 25 mEq/L)
- Vomiting / NG suction (most common)
- Diuretic use (after diuretic effect wanes)
- Post-hypercapnic alkalosis
- Villous adenoma (chloride-losing diarrhea)
- Cystic fibrosis (sweat chloride losses)
Chloride-resistant (UCl > 40 mEq/L)
- Primary hyperaldosteronism (Conn syndrome) — hypertension + hypokalemia [2][5]
- Cushing syndrome / ectopic ACTH
- Renovascular hypertension
- Liddle syndrome, 11β-HSD deficiency (apparent mineralocorticoid excess) [5]
- Bartter syndrome, Gitelman syndrome (normotensive) [2][5]
- Severe hypokalemia (K < 2 mEq/L) [2]
- Severe hypomagnesemia
Exogenous alkali load
- Milk-alkali syndrome (calcium carbonate excess) [4]
- Massive blood transfusion (citrate load)
- Bicarbonate administration / TPN with acetate [4]
Cannot-miss mimics
- Respiratory alkalosis (primary hyperventilation — PE, sepsis, CNS pathology)
- Mixed acid-base disorders (concurrent metabolic alkalosis + respiratory alkalosis can produce dangerously high pH) [2]
9. Past Medical History
- CHF (diuretic-induced alkalosis is extremely common) [8]
- CKD/ESRD (impaired bicarbonate excretion)
- Cirrhosis (secondary hyperaldosteronism)
- Prior episodes of vomiting, bulimia, or GI surgery (gastric outlet obstruction)
- Adrenal disorders (Cushing, Conn)
- History of pyloric stenosis (infants)
10. Physical Exam
Vital signs
- Tachycardia, hypotension/orthostasis (volume depletion in chloride-responsive forms)
- Hypertension (suggests mineralocorticoid excess — chloride-resistant) [2]
- Shallow, slow respirations (compensatory hypoventilation) [1]
Focused exam
- Volume status: Skin turgor, mucous membranes, JVP, peripheral edema
- Neuro: Chvostek sign, Trousseau sign (hypocalcemia from alkalemia), hyperreflexia, tremor, altered mental status [4]
- Cardiac: Irregular rhythm (arrhythmias from hypokalemia)
- Abdominal: Distension, succussion splash (gastric outlet obstruction), surgical scars
- Skin: Cushingoid features, striae (cortisol excess)
11. Lab Studies
Essential labs
- ABG/VBG: pH, pCO2, HCO3 — confirm metabolic alkalosis and assess compensation
- BMP: Na, K, Cl, HCO3, BUN, Cr, glucose, Ca
- Urine chloride (spot) — the pivotal test: <25 mEq/L = chloride-responsive; >40 mEq/L = chloride-resistant [2]
- Magnesium — severe deficiency maintains alkalosis and must be corrected [2]
- Serum albumin — correct anion gap; hypoalbuminemia can mask concurrent anion gap acidosis [3]
Additional labs when indicated
- Urine potassium, urine sodium
- Plasma renin activity and aldosterone level (if chloride-resistant + hypertension) [2]
- Cortisol / ACTH (if Cushing suspected)
- Urine drug screen for diuretics (surreptitious use)
- Serum anion gap — metabolic alkalosis itself can raise the AG by 4–6 mEq/L due to hemoconcentration and albumin charge changes [2]
12. Imaging
- Not routinely indicated for metabolic alkalosis itself
- CT abdomen: If gastric outlet obstruction suspected (vomiting, succussion splash)
- CT adrenals: If primary hyperaldosteronism confirmed biochemically [2]
- Renal artery imaging (CTA/MRA or duplex): If renovascular hypertension suspected
- Chest X-ray: If CHF exacerbation or respiratory compromise
13. Special Tests
- Urine chloride — the single most important diagnostic test to classify metabolic alkalosis [2-3]
- Saline infusion test: Therapeutic and diagnostic — improvement confirms chloride-responsive etiology
- Aldosterone-to-renin ratio (ARR): Screening for primary hyperaldosteronism
- Saline suppression test / adrenal vein sampling: Confirmatory for Conn syndrome
- Genetic testing: Bartter, Gitelman, Liddle syndromes when clinically suspected [5]
14. ECG
- Indications: All patients with significant hypokalemia (K < 3.0 mEq/L) or severe alkalemia
- Hypokalemia findings: Flattened T waves, ST depression, prominent U waves, prolonged QT/QU interval
- Dangerous patterns: Ventricular ectopy, torsades de pointes, VT/VF — especially with concurrent digitalis use [4]
- Arrhythmias: Alkalemia lowers the anginal threshold and predisposes to both supraventricular and ventricular arrhythmias [4]
15. Assessment
Severity stratification
- Mild: HCO3 28–34 mEq/L, pH < 7.50 — often asymptomatic
- Moderate: HCO3 35–45 mEq/L, pH 7.50–7.55
- Severe/life-threatening: HCO3 > 45 mEq/L, pH ≥ 7.55 — associated with significantly increased mortality [1][4]
Typical presentation: Volume-depleted patient with vomiting or on diuretics, hypochloremic hypokalemic metabolic alkalosis, paradoxical aciduria (urine pH < 6 despite systemic alkalemia) [7]
Complications: Cardiac arrhythmias, seizures, impaired oxygen delivery (leftward shift of oxyhemoglobin curve acutely), hepatic encephalopathy precipitation (increased ammonia production), ventilator weaning failure [4]
16. Treatment Plan
Initial stabilization
- ABCs; cardiac monitoring; IV access
- Correct life-threatening hypokalemia first (K < 2.5 mEq/L → IV KCl 10–20 mEq/hr via central line with continuous telemetry)
Chloride-responsive metabolic alkalosis (majority of cases):
- 0.9% NaCl — aggressive volume resuscitation to restore effective circulating volume [2][7]
- KCl repletion — both IV and oral; alkalosis will not correct without potassium repletion [7]
- Stop offending agents: Hold/reduce diuretics; discontinue NG suction if possible; stop alkali-containing infusions [4]
- Antiemetics for ongoing vomiting; PPI/H2-blocker if NG drainage must continue [4]
- Acetazolamide 250–375 mg IV/PO once or twice daily — useful adjunct, especially in volume-overloaded patients (CHF) where saline is contraindicated; monitor potassium closely [4][8]
Chloride-resistant metabolic alkalosis
- Treat underlying cause (surgical resection of aldosteronoma, treat Cushing) [4]
- Aggressive KCl repletion [4]
- Spironolactone or amiloride — especially for mineralocorticoid excess or CHF [4][8]
- NSAIDs or ACE inhibitors — for Bartter/Gitelman syndromes [4]
Refractory/life-threatening (pH > 7.60)
- Hydrochloric acid infusion (0.1–0.2 N HCl via central line) — titrate to reduce HCO3 to < 40 mEq/L [4]
- Hemodialysis with low-bicarbonate dialysate — for concurrent renal failure or volume overload [4][8]
- CRRT with NaCl replacement solution for hemodynamically unstable patients [4]
Magnesium: Always check and replete — hypomagnesemia perpetuates both hypokalemia and alkalosis [2]
17. Disposition
Admit (inpatient/ICU)
- pH ≥ 7.55 or HCO3 > 45 mEq/L [1][4]
- Severe hypokalemia (K < 2.5 mEq/L) or symptomatic hypokalemia
- Cardiac arrhythmias or ECG changes
- Altered mental status, seizures, tetany [4]
- Hemodynamic instability
- Inability to tolerate oral intake with ongoing losses
- Need for IV HCl or dialysis
Observation
- Moderate alkalosis (pH 7.50–7.55) responding to IV fluids and electrolyte repletion
- Stable vitals, tolerating PO, identifiable and correctable cause
Discharge
- Mild alkalosis with identified and corrected cause (e.g., resolved vomiting, diuretic dose adjusted)
- Electrolytes trending toward normal, tolerating PO
- Reliable follow-up arranged
Specialist consultation triggers
- Nephrology: Refractory alkalosis, need for dialysis, suspected tubulopathy
- Endocrinology: Suspected mineralocorticoid excess (hyperaldosteronism, Cushing)
- Surgery: Gastric outlet obstruction, adrenalectomy for Conn syndrome
18. Follow Up / Return Precautions
- Follow-up timing: Repeat BMP within 24–48 hours if discharged; sooner if diuretic regimen was changed
- Return immediately for: Persistent vomiting, palpitations, muscle weakness, confusion, seizures, syncope, inability to keep fluids down
- Patient counseling:
- Importance of medication adherence and not self-adjusting diuretic doses
- Avoid excessive antacid use
- Maintain adequate oral hydration and dietary potassium
- If eating disorder suspected — compassionate referral to appropriate services
- Expected recovery: Chloride-responsive metabolic alkalosis typically corrects within 24–48 hours with adequate saline and potassium repletion. Chloride-resistant forms require treatment of the underlying cause and may take longer. [7]
References
1. Metabolic Alkalosis Pathogenesis, Diagnosis, and Treatment: Core Curriculum 2022. — Do C, Vasquez PC, Soleimani M. American Journal of Kidney Diseases : The Official Journal of the National Kidney Foundation. 2022.
2. Physiological Approach to Assessment of Acid–Base Disturbances. — Berend K, de Vries AP, Gans RO. The New England Journal of Medicine. 2014.
3. Severe Multifactorial Metabolic Alkalosis in the Emergency Department: A Case Report. — Lukomskyj AO, Partyka CL. The Journal of Emergency Medicine. 2024.
4. Management of Life-Threatening Acid–Base Disorders. — Adrogué HJ, Madias NE. The New England Journal of Medicine. 1998.
5. Hypokalemia. — Gennari FJ. The New England Journal of Medicine. 1998.
6. Peripheral Venous Blood Gas Analysis for the Diagnosis of Respiratory Failure, Hypercarbia and Metabolic Disturbance in Adults. — Byrne AL, Pace NL, Thomas PS, et al. The Cochrane Database of Systematic Reviews. 2025.
7. Integration of Acid–Base and Electrolyte Disorders. — Seifter JL. The New England Journal of Medicine. 2014.
8. Treatment of Severe Metabolic Alkalosis in a Patient With Congestive Heart Failure. — Peixoto AJ, Alpern RJ. American Journal of Kidney Diseases : The Official Journal of the National Kidney Foundation. 2013.
9. Acid-Base Disorders in the Critically Ill Patient. — Achanti A, Szerlip HM. Clinical Journal of the American Society of Nephrology : CJASN. 2023.